Does MTHFD1 rs2236225 AG constrain one-carbon folate flux and show up as macrocytosis?

Mechanistic pathway dynamics

• The MTHFD1 rs2236225 (G1958A) polymorphism causes an Arg653Gln amino acid substitution in the 10-formyl-THF synthetase domain, significantly compromising the enzyme's thermal stability.
• Individuals with the heterozygous AG genotype experience a partial reduction in MTHFD1 activity, constraining cytosolic one-carbon folate flux and limiting formate integration into the folate pool.
• This genetic constraint increases susceptibility to choline deficiency, creating a higher physiological demand for both dietary folate and choline to sustain remethylation and nucleotide synthesis.

Hematologic and functional markers of cellular strain

• Elevated mean corpuscular volume (MCV) and red cell distribution width (RDW) serve as downstream hematologic markers of impaired bone marrow DNA synthesis.
• These markers can reflect functional cellular folate or vitamin B12 strain even when extracellular serum folate appears normal. While serum folate levels reflect transient dietary intake, cellular-level entrapment (such as the "methyl-folate trap" locking folate as 5-methyltetrahydrofolate) halts intracellular utilization.
• To resolve discrepancies between normal serum levels and suspected cellular strain, functional biomarkers such as elevated plasma homocysteine and methylmalonic acid (MMA) are highly sensitive indicators of tissue-level insufficiency.

Bottom line

• The MTHFD1 rs2236225 AG genotype imposes a functional constraint on one-carbon flux that increases nutritional requirements, which can manifest as cellular folate/B12 pathway strain (marked by elevated MCV, RDW, homocysteine, or MMA) despite normal circulating serum folate levels.